Moneta Group Investment Advisors LLC Insulet Corp Transaction History

Moneta Group Investment Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	BUY	$272.48 - $330.23 $14,441 - $17,502	53 Added 7.68%	743 $214,000
Q1 2023 May 15, 2023	SELL	$276.36 - $326.03 $172,448 - $203,442	-624 Reduced 47.49%	690 $220,000
Q4 2022 Feb 16, 2023	BUY	$212.22 - $313.46 $2,971 - $4,388	14 Added 1.08%	1,314 $386,000
Q4 2022 Feb 16, 2023	SELL	$212.22 - $313.46 $276 Million - $407 Million	-1,299,077 Reduced 99.9%	1,300 $382,000
Q4 2022 Feb 15, 2023	BUY	$212.22 - $313.46 $276 Million - $407 Million	1,299,095 Added 101333.46%	1,300,377 $383 Million

Q3 2022 Nov 14, 2022	SELL	$224.6 - $281.45 $54,128 - $67,829	-241 Reduced 15.82%	1,282 $294,000
Q2 2022 Aug 15, 2022	BUY	$186.4 - $279.02 $283,887 - $424,947	1,523 New	1,523 $332,000

613

62.9M

339K

916K

Ticker PODD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 69,403,600
Market Cap $13.7B
Description
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...

Get notified when there are updates to the investment portfolio of Moneta Group Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Moneta Group Investment Advisors LLC with notifications on news.